DOI 10.1016/j.aicoj.2026.100114
Extracorporeal CO2 removal integrated with continuous renal replacement therapy in patients with acute respiratory distress syndrome and acute kidney injury: a systematic review and meta-analysis.
Аннотация
INTRODUCTION
Patients with acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) represent a complex clinical scenario. Permissive hypercapnia during lung-protective ventilation may cause severe acidemia and limit further reductions in ventilatory intensity. Extracorporeal carbon dioxide removal integrated into the CRRT circuit may enhance carbon dioxide clearance while providing renal support, but its physiological effects and safety in this population remain uncertain.
METHODS
We conducted a systematic review and meta-analysis of adult studies evaluating ECCO2R integrated with continuous RRT in patients with ARDS and AKI. Literature searches were performed in PubMed, Embase (Ovid), and Cochrane CENTRAL from inception to May 15, 2026, without language or date restrictions, and were supplemented by reference screening, forward citation tracking, and trial registry searches. The primary outcomes were changes in PaCO2 and arterial pH after treatment initiation. Secondary outcomes included changes in ventilatory parameters, clinical outcomes, and safety events. Pre-post changes were pooled using random-effects models with restricted maximum likelihood estimation.
RESULTS
Seven observational studies comprising 105 patients were included. ECCO2R integrated with RRT was associated with sustained reductions in PaCO2 at 2 h (mean difference [MD] -8.22 mmHg; 95% CI -12.00 to -4.44), 6 h (MD -9.02 mmHg; 95% CI -15.69 to -2.34), and 24 h (MD -9.10 mmHg; 95% CI -13.59 to -4.61). These changes were accompanied by increases in arterial pH at 2 h (MD + 0.05; 95% CI 0.02 to 0.08) and 24 h (MD + 0.06; 95% CI 0.02 to 0.11). Ventilatory variables also improved, with reductions in tidal volume normalized to predicted body weight (MD -1.14 mL/kg PBW; 95% CI -1.74 to -0.54), driving pressure (MD -3.61 cmH2O; 95% CI -4.87 to -2.35), and mechanical power (MD -6.82 J/min; 95% CI -9.12 to -4.51). Safety and patient-centered outcomes were limited and heterogeneously reported.
CONCLUSION
ECCO2R integrated with CRRT was associated with early PaCO2 reduction, pH improvement, and lower ventilatory intensity in patients with ARDS and AKI. These findings support the physiological feasibility of this combined approach, although prospective comparative studies are needed to define its clinical role, safety, and impact on patient-centered outcomes.
TRIAL REGISTRATION: PROSPERO CRD420251234033.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.